Entities / Company
SIGA Technologies.
American pharmaceutical
- Reports this week
- 0
- Active events
- 0
- Connections
- 53
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
One to three months ago
Gone quiet
No new reports in 90+ days-
SIGA Technologies received an analyst upgrade from Weiss Ratings and trades on the Nasdaq stock exchange.Some support1 report
-
Siga Technologies stock underperformed the S&P 500 gain but led the Medical sector gain on July 25, 2025.Some support7 reports
-
SIGA Technologies received international approvals for its TPOXX smallpox treatment in Europe, the U.K., Canada, and Japan.Some support2 reports
-
SIGA Technologies received U.S. Government funding under the BARDA 19C Contract for deliveries to the Strategic National Stockpile.Well supported3 reports
No events began in the chosen period. Widen it, or reset.
Around SIGA Technologies this week
News at the entities that move SIGA Technologies most-
Nasdaq StructuralCoinbase announced its listing on Nasdaq, expanded its use of the Base blockchain for settlement, and is deepening its partnership with Marqeta.Moves SIGA Technologies
-
FDA OperationalAbbott Laboratories faces an FDA recall classification of its sensors, while Ken Fisher and Donald Trump engage in stock transactions.Moves SIGA Technologies
-
Department of Health & Human Services StructuralPresident instructs HHS to set up a Women's Health Division, and Robert F. Kennedy Jr. heads a new White House task force.Moves SIGA Technologies
-
Europe Shared contextAdisseo, a subsidiary of China National BlueStar, operates facilities across Europe and Thailand.Moves SIGA Technologies
Connections
The 6 strongest of 53, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Diem Nguyen Structural
Diem Nguyen serves as the Chief Executive Officer of SIGA Technologies.
-
Nasdaq Structural
SIGA Technologies is formally listed and trades on the Nasdaq stock exchange.
-
FDA Operational
SIGA Technologies relies on the FDA for market approval and submission processes for its products.
-
Department of Health & Human Services Structural
SIGA Technologies supplies products to the Department of Health & Human Services stockpile.
-
Incepta Pharmaceuticals Shared context
Both companies operate within the shared context of the Medical - Drugs industry sector.
-
Europe Shared context
SIGA Technologies is obtaining regulatory approvals and market authorizations for its products within Europe.
History
Events by the month they beganAugust 2026
1 eventJune 2026
4 events- SIGA Technologies received an analyst upgrade from Weiss Ratings and trades on the Nasdaq stock exchange.
- Siga Technologies stock underperformed the S&P 500 gain but led the Medical sector gain on July 25, 2025.
- SIGA Technologies received international approvals for its TPOXX smallpox treatment in Europe, the U.K., Canada, and Japan.
- SIGA Technologies received U.S. Government funding under the BARDA 19C Contract for deliveries to the Strategic National Stockpile.